Kidney Stones: Treatment Options
Urologist, Dr. Steven Savage, talks about the different types of kidney stones such as calcium stones and uric acid stones and explains how kidney stones are diagnosed. Dr. Savage discusses the advances in recent years to treat kidney stones using techniques like shock waves or extracorporeal shock wave lithotripsy and ureteroscope, which is when a long wire with a camera attached to it is inserted it into the patient's urethra and passed up through the bladder to the ureter where the stone is located. (Source: MUSC Urology Podcast)
Source: MUSC Urology Podcast - April 5, 2014 Category: Urology & Nephrology Authors: Medical Univeristy of South Carolina Source Type: podcasts
Calcium Density of Coronary Artery Plaque and Risk of Incident Cardiovascular Events
Interview with Michael H. Criqui, MD, MPH, author of Calcium Density of Coronary Artery Plaque and Risk of Incident Cardiovascular Events (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - January 14, 2014 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JAMA 2014-01-14, Vol. 311, No. 3, Audio from Weekly Author Video Interview
Interview with Michael H. Criqui, MD, MPH, author of Calcium Density of Coronary Artery Plaque and Risk of Incident Cardiovascular Events (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - January 14, 2014 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JAMA 2013-12-17, Vol. 310, No. 23, Author Audio Interview
Interview with Amit X. Garg, MD, PhD, author of Calcium-Channel Blocker–Clarithromycin Drug Interactions and Acute Kidney Injury (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - December 17, 2013 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Calcium-Channel Blocker-Clarithromycin Drug Interactions and Acute Kidney Injury
Interview with Amit X. Garg, MD, PhD, author of Calcium-Channel Blocker-Clarithromycin Drug Interactions and Acute Kidney Injury (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - December 17, 2013 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Calcium + Vitamin D: Surprises From Long-term Follow-up
Dr. JoAnn Manson discusses whether calcium plus vitamin D supplementation is beneficial for bone health. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - December 11, 2013 Category: OBGYN Authors: Medscape Source Type: podcasts
CCBs and Breast Cancer: Let's Get Some Perspective
Henry Black has some questions regarding a recent study suggesting that calcium channel blockers pose a risk for breast cancer. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - September 13, 2013 Category: Cardiology Authors: Medscape Source Type: podcasts
Bariatric surgery, neuromuscular blocking agents, and calcium in primary parahyperthyroidism
Bariatric surgery is under scrutiny from NCEPOD, the National Confidential Enquiry into Patient Outcome and Death, Ian Martin, NCEPOD's clinical co-ordinator for surgery, takes us through the highlights of its latest report. Also this week, Julie Paik, instructor and physician at Harvard Medical School, tells us about a new risk factor for primary... (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 27, 2013 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Bariatric surgery, neuromuscular blocking agents, and calcium in primary parahyperthyroidism
Bariatric surgery is under scrutiny from NCEPOD, the National Confidential Enquiry into Patient Outcome and Death, Ian Martin, NCEPOD's clinical co-ordinator for surgery, takes us through the highlights of its latest report. Also this week, Julie Paik, instructor and physician at Harvard Medical School, tells us about a new risk factor for primary hyperparathyroidism. And finally, some neuromuscular agents may lead to respiratory complications after surgery. Matthias Eikermann, director of research in the surgical intensive care unit at Massachusetts General Hospital, explains how they investigated this vexed problem. (Sou...
Source: The BMJ Podcast - August 27, 2013 Category: General Medicine Authors: BMJ Group Source Type: podcasts
#179: NJ cardiologist received more than $100 000 in referral kickbacks; deaths doubled with high calcium intake plus supplements; widely used diclofenac associated with increased risk of CV events; functional evaluation of CAD using angiographic images
NJ cardiologist received more than $100 000 in referral kickbacks; deaths doubled with high calcium intake plus supplements; widely used diclofenac associated with increased risk of CV events; functional evaluation of CAD using angiographic images alone (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - February 22, 2013 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
JAMA: 2012-08-22, Vol. 308, No. 8, Author in the Room™ Audio Interview
Interview with Philip Greenland, MD, author of Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals. Summary Points:
In comparison with other competing biomarkers and risk factors, coronary artery calcium (CAC) is currently the most potent risk marker of subclinical coronary heart disease (CHD).
CAC was shown in several observational studies to improve the prediction of risk beyond traditional risk factors.
In this JAMA paper, CAC outperformed various competing risk assessment markers among asymptomatic people at intermediate risk for CHD. Whether CAC should b...
Source: JAMA Author in the Room - September 21, 2012 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JAMA: 2012-08-22, Vol. 308, No. 8, Author in the Room ™ Audio Interview
Interview with Philip Greenland, MD, author of Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals. Summary Points:
In comparison with other competing biomarkers and risk factors, coronary artery calcium (CAC) is currently the most potent risk marker of subclinical coronary heart disease (CHD).
CAC was shown in several observational studies to improve the prediction of risk beyond traditional risk factors.
In this JAMA paper, CAC outperformed various competing risk assessment markers among asymptomatic people at intermediate risk for CHD. Whether CAC should b...
Source: JAMA Author in the Room - September 21, 2012 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
